- Guide to PHARMACOLOGY
Molecular properties generated using the CDK
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|Compound class||Synthetic organic|
|Ligand families/groups||Antimalarial ligands|
|International Nonproprietary Names|
|KAE609 | NITD609|
|Cipargamin is an antimalarial drug candidate, under clinical development. It is the optimised lead for the spiroindolones, a novel class of compounds identified from a phenotypic screen as having antimalarial activity [2,7] and awarded MMV Project of the Year (2009).
The active enantiomer is shown here, with the 1R,3S configuration essential for antimalarial activity .
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
|CAS Registry No.||1193314-23-6 (source: Scifinder)|
|GtoPdb PubChem SID||374883822|
|Search Google for chemical match using the InChIKey||CKLPLPZSUQEDRT-WPCRTTGESA-N|
|Search Google for chemicals with the same backbone||CKLPLPZSUQEDRT|
|Search PubMed clinical trials||cipargamin|
|Search PubMed titles||cipargamin|
|Search PubMed titles/abstracts||cipargamin|
|Search UniChem for chemical match using the InChIKey||CKLPLPZSUQEDRT-WPCRTTGESA-N|
|Search UniChem for chemicals with the same backbone||CKLPLPZSUQEDRT|